These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 19890354)
1. In vitro and in vivo functional characterization of gutless recombinant SV40-derived CFTR vectors. Mueller C; Strayer MS; Sirninger J; Braag S; Branco F; Louboutin JP; Flotte TR; Strayer DS Gene Ther; 2010 Feb; 17(2):227-37. PubMed ID: 19890354 [TBL] [Abstract][Full Text] [Related]
2. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection. Van Heeckeren AM; Scaria A; Schluchter MD; Ferkol TW; Wadsworth S; Davis PB Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L717-26. PubMed ID: 14514520 [TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro. Kwilas AR; Yednak MA; Zhang L; Liesman R; Collins PL; Pickles RJ; Peeples ME J Virol; 2010 Aug; 84(15):7770-81. PubMed ID: 20504917 [TBL] [Abstract][Full Text] [Related]
4. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway. Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888 [TBL] [Abstract][Full Text] [Related]
5. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Stotland PK; Radzioch D; Stevenson MM Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433 [TBL] [Abstract][Full Text] [Related]
14. A Novel AAV-mediated Gene Delivery System Corrects CFTR Function in Pigs. Cooney AL; Thornell IM; Singh BK; Shah VS; Stoltz DA; McCray PB; Zabner J; Sinn PL Am J Respir Cell Mol Biol; 2019 Dec; 61(6):747-754. PubMed ID: 31184507 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill. Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885 [TBL] [Abstract][Full Text] [Related]
16. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice. Davies LA; Varathalingam A; Painter H; Lawton AE; Sumner-Jones SG; Nunez-Alonso GA; Chan M; Munkonge F; Alton EW; Hyde SC; Gill DR Mol Ther; 2008 May; 16(5):812-8. PubMed ID: 18388934 [TBL] [Abstract][Full Text] [Related]